A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol in the treatment of bronchiectasis
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Mannitol (Primary)
- Indications Bronchiectasis
- Focus Registrational; Therapeutic Use
- Sponsors Pharmaxis
- 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
- 09 Sep 2013 Primary endpoint 'Symptom-exacerbation-rate' has not been met.
- 09 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History